Ibandronate Sodium API molecular structure visualization
Cardiovascular Catalog

Ibandronate Sodium API

A high-potency nitrogen-containing bisphosphonate explicitly engineering flawless osteoclast inhibition for massive postmenopausal osteoporosis treatment ecosystems.

CAS Number

114084-78-5

Formula

C₉H₂₂NNaO₇P₂·H₂O

Mol. Weight

341.23 g/mol

Grade

USP / EP / BP

CEP & USFDA DMF Accessible
Full Monograph Execution
Export Market Clearance
Osteoclast Neutralizer

Product Overview

Ibandronate Sodium functions relentlessly as an extremely high-potency nitrogen-containing bisphosphonate precisely utilized to profoundly and selectively inhibit aggressive osteoclast-mediated bone resorption natively. Its superior molecular bioavailability allows it to serve as the dominant foundational asset for advanced monthly oral formulations and severely intensive intravenous (IV) osteoporosis management systems universally.

As an internationally integrated supplier organization, Jay Overseas explicitly bridges the gap between stringent WHO-GMP regulated endpoints and large-scale commercial market pipelines. We systematically guarantee massive batch perfection, impenetrable assay yielding dynamics, and flawless regulatory compliance frameworks driving heavy long-term commercial formulation scaling explicitly.

Density Reclamation

Stops cascading vertebral structural collapse dynamically safely.

Compliance Matrix

Provides intensely deep technical ICH footprints explicitly.

API Snapshot

CAS Number114084-78-5
Molecular FormulaC₉H₂₂NNaO₇P₂·H₂O
Grade limitsUSP / EP / BP
TherapyNitrogen-Bisphosphonate
Shelf Life36 Months
Request Compliance Data →

Nitrogen-Linked Mechanism

01

Pathological Breakdown

Bone degradation naturally accelerates heavily post-menopause dropping core structural density radically below safety failure thresholds.

02

Selective Accumulation

Ibandronate actively seeks and densely accumulates fiercely localized inside major osteoclast cells residing deep near the resorption edges.

03

Enzyme Disruption

The nitrogen tail heavily interrupts the major osteoclast mevalonate cascade forcing outright cell disruption and massive bone gain inherently.

Medical Matrix Targets

Therapeutic Applications

01

Postmenopausal Repair

Highly aggressive formulation targeting explicitly for the stabilization of severe postmenopausal osteoporosis.

02

Fracture Mitigation

Crucial preemptive clinical stabilization engineered precisely for massive reduction in severe vertebral fracture risk.

03

Intravenous (IV) Dosage

Pure structural formulation dynamically scaling safely within heavily aggressive clinical IV administrations.

04

Extended Oral Compliance

Serves directly as the primary active vector for unique, long-gap monthly oral tableting formulas.

Competitive Edge

Quality & Potency Exuberance

Provides fundamentally massive API potency scaling actively allowing formulation divisions to strictly execute high-dose monthly regimens confidently.

Engineered fundamentally as an exceptionally potent third-generation nitrogen-containing bisphosphonate

Offers uniquely prolonged systemic activity allowing for complex monthly dosing parameters ensuring massive patient compliance

Operates flawlessly under highly stable white crystalline metrics pushing exceptional commercial tableting dynamics

Ensured globally by continuous deep batch traceability firmly anchored into WHO-GMP audited endpoints

Analytical Data

Technical Specifications Matrix

Global DMF ✔ Execution Limits

Sr.Diagnostic ParameterRegulatory Specification Limit
1DescriptionWhite to off-white crystalline powder
2SolubilitySoluble in water; slightly soluble in methanol
3Identification: IR SpectrumConforms fully to reference standard
4pH Value4.5 – 6.0
5Loss on Drying5.0% – 7.0%
6Related Substances (Impurity Profile)Total impurities NMT 1.5%
7Assay (Validated HPLC)98.0% – 102.0%
Commercial Trading Leader

Why Sourcing with Jay Overseas Is Invaluable

We actively maintain profound regulatory compliance to bypass complex clearance friction worldwide.

Global Supply Export

Reliably distributing high-purity execution directly into rapidly growing regulated and heavily semi-regulated networks worldwide.

Flawless Regulatory Base

Fully supported by USFDA DMF filings and integrated CEP layers, formally complying aggressively to USP, EP, and BP monograph baselines.

3rd-Gen Potency Specs

Maintains the highest assay yield parameters expected for third-generation bisphosphonates ensuring incredibly tight impurity profiles.

Export Grade Containment

Deployed routinely securely inside dense double LDPE inner barrier linings structurally packed within 1kg – 25kg HDPE or formal Fiber drum scales.

Ambient Control Parameters

Stored completely locked securely exactly below 30°C parameters aggressively blocking off absolutely any atmospheric moisture or ambient light.

Validated Stability Profiling

Pushes immensely intense longitudinal commercial integrity fully securing formally completely an extended unbroken shelf lifespan up toward 36 months.

Initiate API Formulations Logistics

Secure priority access to comprehensive EU CEP / USFDA DMF documentation chains, extract dedicated volume quotations, and lock in swift international deliveries flawlessly.

Legal Disclaimer: Ibandronate Sodium firmly functions as a dedicated institutional active ingredient. Legally transacted expressly exclusively to profoundly certified, globally licensed pharmaceutical synthesis nodes strictly. Independent consumer availability remains totally locked out indefinitely under global mandates.